Gut Microbiome Science
The 38 trillion microorganisms in your gut are not passengers — they are active regulators of your immunity, metabolism, mood, and longevity. The microbiome is the next frontier of personalised medicine.
38T
Microorganisms in the human gut — outnumbering human cells
70%
Of the immune system resides in the gut
90%
Of the body's serotonin is produced in the gut
FOXO on Nutrition
Eat for your microbiome — the most personalised diet advice you'll ever get.
The Gut-Brain Axis
The enteric nervous system — 500 million neurons lining the GI tract — communicates bidirectionally with the brain via the vagus nerve. Over 90% of the body's serotonin is produced in the gut. Dysbiosis (microbial imbalance) is now linked to depression, anxiety, Parkinson's disease, and autism spectrum disorder. Targeting the gut-brain axis is one of psychiatry's most compelling new frontiers.
Key Insight
Faecal microbiota transplants (FMT) have shown 80–90% remission rates in recurrent C. difficile infection — paving the way for mental health applications.
Personalised Nutrition & Microbiome Testing
Glycaemic response to food varies enormously between individuals — two people eating identical meals can have wildly different blood sugar spikes. Companies like Zoe, Viome, and Thorne leverage microbiome sequencing + CGM data to build personalised nutrition plans. The Weizmann Institute's landmark study showed microbiome composition predicts postprandial glucose response more accurately than food type alone.
Key Insight
Personalised microbiome-based diets outperform standard dietary guidelines in glycaemic control by 2.5× in head-to-head trials.
Probiotics, Postbiotics & Next-Gen Therapeutics
First-generation probiotics (Lactobacillus, Bifidobacterium) are giving way to precision psychobiotics — strains engineered to produce specific neurotransmitters, short-chain fatty acids, and anti-inflammatory metabolites. Akkermansia muciniphila supplementation is showing early promise for metabolic syndrome, obesity, and gut barrier integrity. Live biotherapeutic products (LBPs) are entering FDA pipelines.
Key Insight
The psychobiotics market — targeting mental health via the gut — is projected to reach $6.1B by 2030.
Microbiome & Immune Function
70% of the immune system resides in the gut. Microbial diversity is the single strongest predictor of immune resilience — more predictive than age, BMI, or diet quality alone. Gut dysbiosis is now mechanistically linked to autoimmune conditions (IBD, rheumatoid arthritis, lupus), allergic disease, and reduced vaccine efficacy. Post-COVID-19, research into long COVID's gut microbiome signature is reshaping our understanding of viral persistence.
Key Insight
A 10-unit increase in gut microbiome diversity score correlates with a 24% reduction in systemic inflammation markers.